Evidence mapPaperPMID 33218607Full record

ReviewPET clinics2021

Total-Body PET Imaging of Musculoskeletal Disorders.

Abhijit J Chaudhari, William Y Raynor, Ali Gholamrezanezhad, Thomas J Werner, Chamith S Rajapakse, Abass Alavi

Abstract readReview
In one paragraph

Review in PET clinics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Assessment of Myofascial Trigger Points via Imaging: A Systematic Review.American journal of physical medicine & rehabilitation · 2021
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Role of Total Body PET/CT in Inflammatory Disorders.Seminars in nuclear medicine · 2025
    Review
  6. Review
  7. Review
  8. Radiopharmaceuticals for Skeletal Muscle PET Imaging.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Advantages and Applications of Total-Body PET Scanning.Diagnostics (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abhijit J ChaudhariDepartment of Radiology, University of California Davis, 4860 Y Street, Sacramento, CA 95825, USA. Electronic address: ajchaudhari@ucdavis.edu.
William Y RaynorDepartment of Radiology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA; Drexel University College of Medicine, 2900 West Queen Lane, Philadelphia, PA 19129, USA.
Ali GholamrezanezhadKeck School of Medicine, University of Southern California, 1520 San Pablo Street, Los Angeles, CA 90033, USA.
Thomas J WernerDepartment of Radiology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Chamith S RajapakseDepartment of Radiology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Abass AlaviDepartment of Radiology, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.

Funding

NIAMS NIH HHS R01 AR076088
6 · The paper itself

Abstract

Imaging of musculoskeletal disorders, including arthritis, infection, osteoporosis, sarcopenia, and malignancies, is often limited when using conventional modalities such as radiography, computed tomography (CT), and MR imaging. As a result of recent advances in Positron Emission Tomography (PET) instrumentation, total-body PET/CT offers a longer axial field-of-view, higher geometric sensitivity, and higher spatial resolution compared with standard PET systems. This article discusses the potential applications of total-body PET/CT imaging in the assessment of musculoskeletal disorders.

Indexed as

HumansMusculoskeletal DiseasesMusculoskeletal SystemPositron-Emission TomographyWhole Body ImagingArthritisCancerFever of unknown originOsteoporosisOsteosarcomaPET/CTPET/MR imagingSarcopenia

Identifiers

PMID33218607
PMCPMC7684980

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.